Salugan, Nina H.

HRN: 26-48-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/17/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/17/2026
07/23/2026
IV INFUSION X 1 HR
800mg
OD
Decubitus Ulcer
Checking Final Appropriateness 

Indication:  Culture-directed    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: